Literature DB >> 26393137

Multicentric Metaplastic Breast Carcinoma with Squamous Differentiation.

Sunil Vitthalrao Jagtap1, Suresh J Bhosale2, P G Chougule2, Shrutika D Dhawan3, Dhiraj Shukla3.   

Abstract

Metaplastic breast carcinoma is a rare primary breast malignancy. A 45-year-old female patient presented with multicentric lumps in left breast of 6 months duration and history of axillary lymphadenopathy of 2 months duration. Mammography revealed two high density masses with ill defined margins. Fine needle aspiration cytology was positive for duct carcinoma cells. Histo pathologic examination, reported as "Multicentric infiltrating duct carcinoma with squamous differentiation left breast", grade 2. Immunohistochemistry revealed negativity for ER, PR and positivity for HER-2/neu. We are presenting this rare case for clinical, radiological, histopathological and immunohistochemical study.

Entities:  

Keywords:  Histological subtype; Uncommon breast malignancies

Year:  2015        PMID: 26393137      PMCID: PMC4572969          DOI: 10.7860/JCDR/2015/12794.6218

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  7 in total

1.  Sarcomatoid/metaplastic carcinoma of the breast: a clinicopathological study of 12 cases.

Authors:  Kathreena M Kurian; A Al-Nafussi
Journal:  Histopathology       Date:  2002-01       Impact factor: 5.087

2.  Responses to liposomal Doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: biologic rationale and implications for stem-cell research in breast cancer.

Authors:  Stacy Moulder; John Moroney; Thorunn Helgason; Jennifer Wheler; Daniel Booser; Constance Albarracin; Phuong K Morrow; Kimberly Koenig; Razelle Kurzrock
Journal:  J Clin Oncol       Date:  2011-04-11       Impact factor: 44.544

3.  Metaplastic carcinomas of the breast. IV. Squamous cell carcinoma of ductal origin.

Authors:  E S Wargotz; H J Norris
Journal:  Cancer       Date:  1990-01-15       Impact factor: 6.860

Review 4.  Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature.

Authors:  Alberto Luini; Marisel Aguilar; Giovanna Gatti; Roberta Fasani; Edoardo Botteri; Jack Antonio Diaz Brito; Patrick Maisonneuve; Anna Rita Vento; Giuseppe Viale
Journal:  Breast Cancer Res Treat       Date:  2006-09-29       Impact factor: 4.872

5.  Metaplastic breast cancer: prognosis and response to systemic therapy.

Authors:  D Rayson; A A Adjei; V J Suman; L E Wold; J N Ingle
Journal:  Ann Oncol       Date:  1999-04       Impact factor: 32.976

6.  Metaplastic carcinomas of the breast. III. Carcinosarcoma.

Authors:  E S Wargotz; H J Norris
Journal:  Cancer       Date:  1989-10-01       Impact factor: 6.860

7.  Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study.

Authors:  E A Rakha; P H Tan; Z Varga; G M Tse; A M Shaaban; F Climent; C H M van Deurzen; D Purnell; D Dodwell; T Chan; I O Ellis
Journal:  Br J Cancer       Date:  2014-11-25       Impact factor: 7.640

  7 in total
  1 in total

1.  Metaplastic carcinoma of the breast with squamous differentiation: prognostic factors and multidisciplinary treatment.

Authors:  Ana Alicia Tejera Hernández; Víctor Manuel Vega Benítez; Marta Pavcovich Ruiz; Juan Ramón Hernández Hernández
Journal:  World J Surg Oncol       Date:  2022-06-08       Impact factor: 3.253

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.